Structure | Chemical Name | CAS | MF |
|
2-chloro-5,7-dihydrofuro[3,4-b]pyridine
|
1464091-43-7
|
C7H6ClNO
|
|
Methyl 4-((1-cyclobutyl-4-oxo-4,5,6,7,8,9-hexahydro-3H-pyrazolo[3,4-c]quinolin-3-yl)methyl)picolinate
|
1464091-45-9
|
C22H24N4O3
|
|
Pyrazolo[1,5-a]pyrimidine, 7-chloro-2-(3,4-dimethoxyphenyl)-6-ethyl-5-methyl-
|
1464091-54-0
|
C17H18ClN3O2
|
|
N-(5-Cyclopropyl-2,7-dioxo-1,2,4,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl)acetamide
|
1464091-55-1
|
C11H12N4O3
|
|
2-(trifluoromethyl)quinolin-3-amine
|
1464091-60-8
|
C10H7F3N2
|
|
Methyl 2-amino-4-methyl-5-iodobenzoate
|
1464091-62-0
|
C9H10INO2
|
|
5-(4-Cyclopropyl-4H-1,2,4-triazol-3-yl)thiophen-3-amine
|
1464091-63-1
|
C9H10N4S
|
|
6-broMo-3-ethyl-iMidazo[1,2-a]pyrazine
|
1464091-69-7
|
C8H8BrN3
|
|
1-Pyrrolidinecarboxylic acid, 2-(fluoromethyl)-, 1,1-dimethylethyl ester, (2R)-
|
1464137-21-0
|
C10H18FNO2
|
|
(S)-Benzyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-cyanopropanoate
|
1464137-23-2
|
C26H22N2O4
|
|
(R)-8-((4-(Trifluoromethyl)phenyl)sulfonyl)hexahydropyrazino[2,1-c][1,4]oxazin-4(3H)-one
|
1464137-25-4
|
C14H15F3N2O4S
|
|
ETC-206
|
1464151-33-4
|
C25H20N4O2
|
|
di-tert-butyl (4-chloropyriMidin-2-yl)carbaMate
|
1464788-84-8
|
C14H20ClN3O4
|
|
9H-Carbazole, 9-(7-bromo-9,9-diphenyl-9H-fluoren-2-yl)-
|
1464824-90-5
|
C37H24BrN
|
|
(Z)-Mutagenic Impurity of Tenofovir Disoproxil
|
1464851-21-5
|
C8H9N5
|
|
UPF-648 (sodiuM salt)
|
1465017-87-1
|
C11H9Cl2NaO3
|
|
4-Amino-3-fluoro-5-methylbenzonitrile
|
1465326-80-0
|
C8H7FN2
|
|
methyl 3,5-dichloro-4-formylbenzoate
|
1465326-89-9
|
C9H6Cl2O3
|
|
Ethyl 3-chloro-4-forMylbenzoate
|
1465327-51-8
|
C10H9ClO3
|
|
1-[(4-Methoxyphenyl)Methyl]-3-Methylpiperazine-2,5-Dione
|
1465769-17-8
|
C13H16N2O3
|
|
(S)-6-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride
|
1466429-22-0
|
C9H11BrClN
|
|
5-Methoxyquinolin-4-ol
|
1466525-83-6
|
C10H9NO2
|
|
(S)-2-amino-N-(1-(8-chloro-1-oxo-2-phenyl-1,2-dihydroisoquinolin-3-yl)ethyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
|
1466563-97-2
|
C24H19ClN6O2
|
|
Apixaban Impurity 15
|
1466571-07-2
|
C21H20N4O4
|
|
Sunitinib Impurity 1
|
1467015-10-6
|
C18H18FN3O2
|
|
6-chloro-5-(4-(1-hydroxycyclobutyl)phenyl)-1H-indole-3-carboxylicacid
|
1467057-23-3
|
C19H16ClNO3
|
|
5-bromo-6-chloro-1H-Indole-3-carboxaldehyde
|
1467059-87-5
|
C9H5BrClNO
|
|
methyl 5-bromo-6-chloro-1H-indole-3-carboxylate
|
1467059-91-1
|
C10H7BrClNO2
|
|
5-bromo-1H-Indole-6-carbonitrile
|
1467060-13-4
|
C9H5BrN2
|
|
4‐bromo‐3,5‐difluoro‐2‐iodoaniline
|
1467060-36-1
|
C6H3BrF2IN
|
|
5-bromo-6-chloro-1H-Indazole-3-carboxylic acid
|
1467062-18-5
|
C8H4BrClN2O2
|
|
Hybridaphniphylline A
|
1467083-07-3
|
C37H47NO11
|
|
Hybridaphniphylline B
|
1467083-09-5
|
C37H47NO11
|
|
Daphnicyclidin I
|
1467083-10-8
|
C22H26N2O3
|
|
Adavivint
|
1467093-03-3
|
C29H24FN7O
|
|
3'-bromo-10-phenyl-10H-spiro[acridine-9,9'-fluorene]
|
1467099-22-4
|
C31H20BrN
|
|
3-Bromo-spiro[9H-fluorene-9,8'-[8H]indolo[3,2,1-de]acridine]
|
1467099-23-5
|
C31H18BrN
|
|
[1-(1-methyl-1H-pyrazol-3-yl)propyl]amine
|
1467458-69-0
|
C7H13N3
|
|
Methyl 2-((4-Methylphenylsulfonamido)Methyl)Acrylate
|
1467725-31-0
|
C12H15NO4S
|
|
methyl 2-bromo-1-methyl-1H-imidazole-4-carboxylate
|
1467728-93-3
|
C6H7BrN2O2
|
|
Naphtho[1,2-c:5,6-c'bis[1,2,5]thiadiazole-5,10-diboronic acid bis(pinacol) ester 98% (HPLC)
|
1467776-41-5
|
C22H26B2N4O4S2
|
|
[(3R)-1-[2-[1-(4-Chloro-1H-pyrazol-1-yl)cyclopropyl]-3H-imidazo[4,5-b]pyridin-5-yl]-3-piperidinyl]-1-pyrrolidinyl-methanone methanesulfonate
|
1469284-79-4
|
C23H30ClN7O4S
|
|
1-(4-Chloro-pyrazol-1-yl)-cyclopropanecarboxylicacid
|
1469287-10-2
|
C7H7ClN2O2
|
|
K-Ras(G12C) inhibitor 9
|
1469337-91-4
|
C16H21ClIN3O4S
|
|
1-(4-(2-((4-chloro-2-hydroxy-5-iodophenyl)aMino)acetyl)piperazin-1-yl)prop-2-en-1-one
|
1469337-95-8
|
C15H17ClIN3O3
|
|
K-Ras inhibitor
|
1469338-01-9
|
C20H30ClN3O2S3
|
|
M-5717
|
1469439-69-7
|
C27H31FN4O2
|
|
3,4,5,6-tetrakis(3,6-di-t-Butylcarbazol-9-yl)- 1,2-dicyanobenzene
|
1469705-93-8
|
C88H96N6
|
|
3,4,5,6-tetrakis(3,6-diphenylcarbazol-9-yl)- 1,2-dicyanobenzene
|
1469707-47-8
|
C104H64N6
|
|
PBDTTT‐EFT
|
1469791-66-9
|
(C49H57FO2S6)n
|
|
10928-A5
|
1469800-26-7
|
C15H22O2
|
|
4-(4,6-Bis(4-((2-ethylhexyloxy)carbonyl)phenylaMino)-1,3,5-triazin-2-ylaMino)benzoic Acid
|
1469870-11-8
|
C40H50N6O6
|
|
Dapagliflozin Impurity B
|
1469910-83-5
|
C21H25ClO6
|
|
Dapagliflozin Impurity 19
|
1469910-84-6
|
C29H33ClO10
|
|
Atglistatin
|
1469924-27-3
|
C17H21N3O
|
|
LGB-321 HCl
|
1469925-36-7
|
C23H23ClF3N5O2
|
|
3,5-DICHLOROPYRIDINE-4-BORONIC ACID
|
1469931-06-3
|
C5H4BCl2NO2
|
|
3-(4-BROMOPHENYL)PYRROLIDINE
|
1469974-99-9
|
C10H12BrN
|
|
4-BROMO-6,7-DIHYDRO-5H-CYCLOPENTA[C]PYRIDIN-7-OL(WXC07918)
|
1469979-87-0
|
C8H8BrNO
|
|
ANGIOSTATIN K1-5, HUMAN
|
1469985-12-3
|
C27H44O4
|
|
QL47
|
1469988-75-7
|
C27H21N5O2
|
|
3-Amino-2-methoxy-isonicotinamide
|
1470249-13-8
|
C7H9N3O2
|
|
2,4,8-trichloropyrido[3,4-d]pyrimidine
|
1470249-17-2
|
C7H2Cl3N3
|
|
BrettPhos Pd G3
|
1470372-59-8
|
C48H66NO5PPdS
|
|
4-Bromo-2-(1-hydroxyethyl)pyridine
|
1471260-48-6
|
C7H8BrNO
|
|
Ru-Re(FPh)
|
1471276-06-8
|
C86H72F12N8O2P3ReRu+2
|
|
N-[(1S,2S)-2-(1-pyrrolidinyl)cyclohexyl]-N'-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-Thiourea
|
1471290-67-1
|
C25H39N3O9S
|
|
2-(4-(1,2,2-triphenylvinyl)phenoxy)acetic acid
|
1471339-65-7
|
C28H22O3
|
|
5-Fluoro-2,6-dimethyl-4-pyrimidinamine
|
1472019-35-4
|
C6H8FN3
|
|
8-Cyclopropyl-6-fluoro-3,4-dihydro-2H-1,4-benzoxazepin-5-one
|
1472038-62-2
|
C12H12FNO2
|
|
2-chloro-4-(biphenyl-4-yl)-6-phenyl-1,3,5-triazine
|
1472062-94-4
|
C21H14ClN3
|
|
2-Chloro-4-(1-naphthalenyl)-6-phenyl-1,3,5-triazine
|
1472062-95-5
|
C19H12ClN3
|
|
Methylammonium Lead Chloride Iodide
|
1472068-56-6
|
CH7Cl2INPb
|
|
4-BroMo-2-fluoro-6-Methoxybenzoic acid
|
1472104-49-6
|
C8H6BrFO3
|
|
Pyridostatin TFA salt
|
1472611-44-1
|
C33H33F3N8O7
|
|
7ACC-2
|
1472624-85-3
|
C18H15NO4
|
|
2-Chloro-4-dibenzofuran-4-yl-6-phenyl-[1,3,5]triazine
|
1472729-25-1
|
C21H12ClN3O
|
|
KRCA-0008
|
1472795-20-2
|
C30H37ClN8O4
|
|
(S,E)-N-(1-((5-(2-((4-cyanophenyl)amino)-4-(propylamino)pyrimidin-5-yl)pent-4-yn-1-yl)amino)-1-oxopropan-2-yl)-4-(dimethylamino)-N-methylbut-2-enamide
|
1472797-69-5
|
C29H38N8O2
|
|
5-n-Propylthiophene-2-boronic acid pinacol este
|
1473358-18-7
|
C13H21BO2S
|
|
7-OXASPIRO[3.5]NONAN-1-ONE
|
1473422-93-3
|
C8H12O2
|
|
2,6-Dichloro-4-fluorobenzonitrile
|
1473423-59-4
|
C7H2Cl2FN
|
|
4,6-DICHLORO-N-(4,4-DIMETHYLCYCLOHEXYL)-1H-INDOLE-2-CARBOXAMIDE
|
1473450-60-0
|
C17H20Cl2N2O
|
|
NITD-349
|
1473450-62-2
|
C17H20F2N2O
|
|
11-(Bromomethyl)henicosane
|
1473452-21-9
|
C22H45Br
|
|
Nrf1-activator-1
|
1474034-05-3
|
C33H44F2N2O3
|
|
N-(4-ethylphenyl)-3-(hydroxymethyl)-N-isobutyl-4-((tetrahydro-2H-pyran-4-yl)methoxy)benzenesulfonamide
|
1474110-21-8
|
C25H35NO5S
|
|
N-Desethyl Sunitinib Malate
|
1474111-36-8
|
C24H29FN4O7
|
|
(1R,3S,5R,7R,8aS)-7-Ethylhexahydro-1-(6-hydroxy-4-quinolinyl)-3,7-Methano-1H-pyrrolo[2,1-c][1,4]oxazine
|
1476067-44-3
|
C19H22N2O2
|
|
methyl 4-(2,6-dimethoxyphenyl)-2,4-dioxobutyrate
|
1476068-60-6
|
C13H14O6
|
|
vx984
|
1476074-39-1
|
C23H23N7O
|
|
3-bromo-7-ethoxyquinoline
|
1476078-53-1
|
C11H10BrNO
|
|
tert-butyl (S)-3-(4-bromophenyl)piperidine-1-carboxylate
|
1476776-55-2
|
C16H22BrNO2
|
|
N-(tert-butyl)-1H-indazole-7-carboxamide
|
1476776-76-7
|
C12H15N3O
|
|
Niraparib metabolite M1
|
1476777-06-6
|
C19H19N3O2
|
|
5-bromo-2-(methoxymethyl)pyrimidine
|
1476795-98-8
|
C6H7BrN2O
|
|
4,7-Bis(5-bromothiophen-2-yl)-2-(2-ethylhexyl)-5,6-difluoro-2H-benzo[d][1,2,3]triazole
|
1476807-53-0
|
C22H21Br2F2N3S2
|
|
2-(benzyloxy)-6-hydroxy-4-methoxybenzaldehyde
|
1476847-50-3
|
C15H14O4
|
|
1-(4-(benzyloxy)-6-methoxybenzofuran-2-yl)ethanone
|
1476847-51-4
|
C18H16O4
|
|
1-(4-(benzyloxy)-6-methoxybenzofuran-2-yl)-2-bromoethanone
|
1476847-52-5
|
C18H15BrO4
|